22nd Century Group, Inc.
Stock Promoter Performance
Last 1 Stock Promotions By "Ultimate Stock Alerts"
|KULR||KULR Technology Group, Inc.||June 30, 2021||2.59||-9%|
XXII Promotional Newsletter
The following is a newsletter released by "Ultimate Stock Alerts" promoting 22nd Century Group, Inc.
Don't Want Anymore Emails
New Alert 22nd Century Group, Inc. NASDAQ XXII
XXII is a leading plant biotechnology and intellectual property company focused on improving health and wellness through plant science.
XXII uses modern plant breeding technologies, gene-editing, and molecular breeding to deliver value to its customers in the life science and consumer products industries by creating new, proprietary tobacco, hempcannabis and hop plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.
In addition, the company has also begun to leverage its plant science expertise and existing partnerships to create and commercialize new, proprietary hempcannabis and hop plants to optimize their genetics and create valuable new intellectual property.
XXII was founded to build intellectual property related to nicotine biosynthesis in the tobacco plant and to commercialize its proprietary reduced nicotine content RNC tobacco plants, which have become the cornerstone of FDAs comprehensive plan to address the enormous amount of death and disease caused by addiction to smoking.
Sadly, according to the American Lung Association
While overall cigarette use declined by 26% over the past decade, 91% of that decline was due to non-menthol cigarettes.
Moreover, smoking is the number one preventable cause of death in the U.S., killing over 480,000 people per year.
Despite this, the popularity of these products has been growing
In 2020, disposable e-cigarette use skyrocketed by 1,000% among high school e-cigarette users from 2.4% to 26.5% and 400% among middle school e-cigarette users from 3% to 15.2%.
More than 23.6% of high school students in the U.S. use at least one tobacco product, including e-cigarettes, according to the 2020 National Youth Tobacco Survey.
As the company recently explained
22nd Centurys reduced nicotine content RNC cigarettes, VLN King and VLN Menthol King, contain levels of nicotine content that are minimally or non-addictive, unlike conventional cigarettes that are designed to create and sustain addiction to nicotine.
Made from proprietary tobacco engineered to contain 95% less nicotine than conventional cigarette tobacco, 22nd Centurys RNC cigarettes are the only combustible tobacco products able to meet the nicotine levels proposed in the FDAs ANPRM for a tobacco product standard reduce the nicotine content of all combustible cigarettes.
Since our last update, the company has announced multiple potentially significant accomplishments.
Earlier this summer 22nd Century was added to the Russell 2000, Russell 3000, and Russell Global Indexes at the conclusion of the Russell U.S. Indexes annual reconstitution, effective at the opening of the U.S. equity markets on June 28, 2021. The Russell U.S. Indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.
Most recently, in August, the company announced
22nd Century Group Reports Business Highlights and Financial Results for the Second Quarter 2021
Here are the companys highlights from this press release
Initiated International Launch Process For VLN, First Sales Planned by First Quarter 2022
First Revenue From HempCannabis Franchise to Commence in Second Half of 2021
Third Plant-Based Franchise to be Introduced on August 30, 2021
Uplisting common shares to the Nasdaq Capital Market Nasdaq and will continue to trade under current symbol, XXII
Record Second Quarter Net Sales of $8.4 Million, Up Greater Than 30% From the Second Quarter of 2020
Executing From a Strong Financial Position with Cash and Cash Equivalents of $62.3 Million as of June 30, 2021.
As the company further explained
Our record second quarter and first half net sales were a result of the investments to scale-up our tobacco contract manufacturing capabilities and confirms our ability to generate new business and operate at scale ahead of VLN launches in the U.S. and internationally.
In our hempcannabis franchise, we have secured all key partnerships needed to maximize and support what we believe is the most comprehensive and innovative upstream cannabinoid value chain in the industry, enabling the rapid development of new disruptive plant lines and genetics critical to unlocking commercial success for large-scale cultivation and extraction across this emerging industry. Along with new lines currently growing at our farm in Colorado, we also have plant lines and IP completing the initial two-year development cycle. We look forward to the monetization of these lines and our current hempcannabis portfolio with our first revenue from our hempcannabis franchise expected to commence in the second half of 2021, while we continue the rapid development of next generation, disruptive plant lines for our 2022 and 2023 revenue programs.
Furthermore, just in the past few weeks the company has announced multiple accomplishments.
On August 16, the company announced
22nd Century Group to Ring Nasdaq Closing Bell Today, August 16
Here are the companys comments from this press release
We are thrilled to join the Nasdaq family, and its an honor to celebrate our listing with todays closing bell ceremony, said James A. Mish, chief executive officer of 22nd Century Group. The visibility and exposure we will gain through our uplisting to Nasdaq is an important part of our efforts to build toward the future. Along with our primary mission to reduce the harm caused by smoking, we are actively focused on positioning 22nd Century for long-term revenue growth and driving value creation across multiple plant franchises and global market opportunities.
On August 19, the company announced
22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors
Here are some of the comments from this press release
Anthony is an industry visionary in the biotechnology field and a strategy expert in both domestic and international capacities. He also holds extensive experience with boards and committees, in mentoring businesses and entrepreneurs, and in serving communities, said 22nd Centurys Board Chair, Nora Sullivan. We are fortunate to welcome him to our board of directors where we are confident his contributions will have a significant impact on our Companys business development, commercialization, and value creation efforts.
In addition, yesterday, the company announced potentially big news
22nd Century Group Enters Global Specialty Hops Market
Geographic Expansion into Europe via the Netherlands
As the company explains
Following the exciting progress in our tobacco and hempcannabis franchises detailed on our second quarter results conference call earlier this month, I am proud to announce our third plant-based franchise the global specialty hops market. Like our existing franchises, the hop plant market is ripe for disruption and offers opportunities for 22nd Century to provide unique and significant competitive advantages to commercial partners. The addition of hops, a critical input for the $500 billion global brewing industry as well as a growing source of medically-important molecules, expands our total addressable markets to an estimated $1.3 trillion.
XXII could be in a position to experience increased growth.
Make sure to do your own due diligence.
Sources , , , , , , , , , ,
Note We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term opportunities. Before investing in securities, you should always consult with your financial, tax and legal advisor and never invest money you cannot afford to lose.
You should read and understand this disclaimer in its entirety before joining the website or emailblog list of UltimateStockAlerts.com the Publisher. The information collectively the Advertisement disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, andor losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply.
The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission the SEC at www.sec.gov the Financial Industry Regulatory Authority the FINRA at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.govconsumercyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.
The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial andor legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.
Owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 82321 for the distribution of this advertisement about XXII dated 83121. Previously, owners and operators of the Publisher have been compensated twenty five thousand dollars by bank wire transfer on 62521 for the distribution of a prior advertisement about XXII. Previously, owners and operators of the Publisher have been compensated twenty two thousand five hundred dollars by bank wire transfer on 42121 for the distribution of a prior advertisement about XXII. Prior to the past year, at the time of publication, we disclosed our compensation for the distribution of advertisements about XXII. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in the Advertisement. Owners and operators of the Publisher own several newsletters, therefore you may receive multiple publications and emails featuring companies at different or the same time.
www.UltimateStockAlerts.comDisclaimer and www.UltimateStockAlerts.comPrivacy-Policy
By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of 1 a client company, 2 the party issuing or preparing the information for the company, or 3 other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated reportrelease or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.
Our records indicate that . requested and confirmed to be added to UltimateStockAlerts.com on January 26, 2015.
6020 Bent Pine Dr, Orlando, FL 32822, USA
Get Every Penny Stock Alert!
OTC Dynamics tracks all penny stock promotions. Become a member today and never miss another penny stock promotion!
OTC Dynamics is not affiliated with the company being promoted or the associated stock promoter.
The information on this page is not a recommendation to buy or sell securities.